Teladoc Brass Must Face Derivative Suit, Shareholders Say
Two investors in telemedicine giant Teladoc on Wednesday alleged that the company's brass exhibited a "years-long pattern of defending, excusing, and ignoring" misconduct by a member of its ranks, and so...To view the full article, register now.
Already a subscriber? Click here to view full article